Pages that link to "Q50893607"

The following pages link to Stop Alzheimer's before it starts (Q50893607):

Displaying 42 items.

• Anti-Aβ single-chain variable fragment antibodies restore memory acquisition in a Drosophila model of Alzheimer's disease (Q41199012) (← links)
• Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies. (Q46240783) (← links)
• Next generation antibody drugs: pursuit of the 'high-hanging fruit'. (Q46527001) (← links)
• Fluid biomarker agreement and interrelation in dementia due to Alzheimer's disease (Q47573970) (← links)
• BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer's Disease Pathology. (Q47658329) (← links)
• β-Amyloid and the Pathomechanisms of Alzheimer's Disease: A Comprehensive View (Q47672665) (← links)
• Human Neurospheroid Arrays for In Vitro Studies of Alzheimer's Disease (Q48102996) (← links)
• Discovery of Selective, Substrate-Competitive, and Passive Membrane Permeable Glycogen Synthase Kinase-3β Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling of New C-Glycosylflavones (Q49577179) (← links)
• A roadmap towards personalized immunology. (Q50104991) (← links)
• The cholinergic system in the pathophysiology and treatment of Alzheimer's disease (Q57177786) (← links)
• Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease? (Q57418361) (← links)
• The Early Events That Initiate β-Amyloid Aggregation in Alzheimer's Disease (Q59808453) (← links)
• Advances in Resting State Neuroimaging of Mild Cognitive Impairment (Q60046152) (← links)
• Investigation of the neuroprotective effects of crocin via antioxidant activities in HT22 cells and in mice with Alzheimer's disease (Q61444479) (← links)
• Protective roles of isoastilbin against Alzheimer's disease via Nrf2‑mediated antioxidation and anti‑apoptosis (Q61797827) (← links)
• Impaired Spatial Reorientation in the 3xTg-AD Mouse Model of Alzheimer's Disease (Q61800973) (← links)
• Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers (Q64064005) (← links)
• (Q64765358) (← links)
• Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease. (Q64946523) (← links)
• Is Sleep Disruption a Cause or Consequence of Alzheimer's Disease? Reviewing Its Possible Role as a Biomarker (Q89682688) (← links)
• Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease (Q89747430) (← links)
• Complex interactions underlie racial disparity in the risk of developing Alzheimer's disease dementia (Q89750278) (← links)
• A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials (Q90043569) (← links)
• Towards a treatment for genetic prion disease: trials and biomarkers (Q90559209) (← links)
• Astaxanthin Ameliorated Parvalbumin-Positive Neuron Deficits and Alzheimer's Disease-Related Pathological Progression in the Hippocampus of AppNL-G-F/NL-G-F Mice (Q90697479) (← links)
• The rare and the common: scale and the genetic imaginary in Alzheimer's disease drug development (Q91634060) (← links)
• Predictive Value of Routine Peripheral Blood Biomarkers in Alzheimer's Disease (Q92187862) (← links)
• Dampened Slow Oscillation Connectivity Anticipates Amyloid Deposition in the PS2APP Mouse Model of Alzheimer's Disease (Q92286344) (← links)
• Short amylin receptor antagonist peptides improve memory deficits in Alzheimer's disease mouse model (Q92266507) (← links)
• Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease (Q92556485) (← links)
• Design and sample size considerations for Alzheimer's disease prevention trials using multistate models (Q92680355) (← links)
• Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development (Q92766222) (← links)
• Brain Structural Correlates of Odor Identification in Mild Cognitive Impairment and Alzheimer's Disease Revealed by Magnetic Resonance Imaging and a Chinese Olfactory Identification Test (Q93046692) (← links)
• Circulating Exosomal miRNA as Diagnostic Biomarkers of Neurodegenerative Diseases (Q94464057) (← links)
• Circulating MicroRNAs as Diagnostic Biomarkers for Motor Neuron Disease (Q94560701) (← links)
• Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer's disease (Q95579827) (← links)
• The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease (Q96127618) (← links)
• Potential human transmission of amyloid β pathology: surveillance and risks (Q99573889) (← links)
• Impact of Mutations on the Conformational Transition from α-Helix to β-Sheet Structures in Arctic-Type Aβ40: Insights from Molecular Dynamics Simulations (Q99585051) (← links)
• The efficacy and safety of hachimijiogan for mild Alzheimer disease in an exploratory, open standard treatment controlled, randomized allocation, multicenter trial: A study protocol (Q99590871) (← links)
• Lower brain-derived neurotrophic factor levels are associated with age-related memory impairment in community-dwelling older adults: the Sefuri study (Q100455011) (← links)
• Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life (Q102075576) (← links)